HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.64B
This Quarter Return
+2.66%
1 Year Return
+13.46%
3 Year Return
+46.51%
5 Year Return
+54.89%
10 Year Return
+86.85%
AUM
$8.64M
AUM Growth
Cap. Flow
+$8.44M
Cap. Flow %
97.66%
Top 10 Hldgs %
59.99%
Holding
94
New
91
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Financials 22.99%
2 Technology 19.47%
3 Consumer Staples 16.95%
4 Healthcare 15.06%
5 Industrials 7.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TCRT icon
51
Alaunos Therapeutics
TCRT
$4.21M
$3K 0.03%
+1,252
New +$3K
PVFC
52
DELISTED
PVF CAPITAL CORP
PVFC
$1K 0.01%
+200
New +$1K
MHA
53
DELISTED
MANHATTAN PHARM INC
MHA
$1K 0.01%
+5,366
New +$1K
ASMB icon
54
Assembly Biosciences
ASMB
$190M
$0 ﹤0.01%
+166
New
CRMD icon
55
CorMedix
CRMD
$1.11B
$0 ﹤0.01%
+256
New
UIS icon
56
Unisys
UIS
$279M
$0 ﹤0.01%
+10
New
HEAL
57
Global X Funds Global X HealthTech ETF
HEAL
$44.8M
$0 ﹤0.01%
+12,868
New
WINT
58
DELISTED
Windtree Therapeutics Inc
WINT
$0 ﹤0.01%
+226
New
VRSO
59
DELISTED
VERSO TECHNOLOGIES INC
VRSO
$0 ﹤0.01%
+800
New